Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension (PREVER)

This study has been completed.
Financiadora de Estudos e Projetos
Information provided by (Responsible Party):
Flávio Danni Fuchs, Hospital de Clinicas de Porto Alegre Identifier:
First received: September 2, 2009
Last updated: February 11, 2015
Last verified: February 2015